US Stock MarketDetailed Quotes

JANX Janux Therapeutics

Watchlist
  • 50.200
  • +0.220+0.44%
Close Sep 20 16:00 ET
  • 50.200
  • 0.0000.00%
Post 16:39 ET
2.62BMarket Cap-57045P/E (TTM)

Janux Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
33.43%-10.02M
-6.66%-14.84M
-17.83%-50.58M
16.89%-9.9M
12.71%-11.71M
-147.88%-15.05M
-20.73%-13.91M
-152.84%-42.92M
-13.66%-11.91M
-129.14%-13.41M
Net income from continuing operations
65.96%-5.96M
15.46%-14.76M
7.56%-58.29M
26.81%-11.76M
30.71%-11.57M
-3.67%-17.51M
-30.19%-17.46M
-93.01%-63.06M
-19.75%-16.07M
-55.08%-16.7M
Depreciation and amortization
7.43%506K
17.44%532K
132.46%1.96M
31.76%531K
100.80%500K
336.11%471K
459.26%453K
644.25%841K
529.69%403K
822.22%249K
Change In working capital
-338.40%-7.35M
-535.29%-4.45M
-253.27%-6.55M
-231.10%-1.1M
-287.55%-3.08M
-126.36%-1.68M
67.09%-700K
-51.64%4.28M
5,673.33%836K
-133.15%-795K
-Change in receivables
-1,030.80%-6.98M
30.80%-519K
----
----
--0
--750K
---750K
----
----
----
-Change in prepaid assets
21.30%-1.76M
-171.01%-1.17M
106.23%210K
433.33%270K
140.74%530K
-281.43%-2.24M
217.79%1.65M
-86.65%-3.37M
-400.00%-81K
-2,925.58%-1.3M
-Change in payables and accrued expense
86.01%2.37M
-204.20%-2.03M
-110.38%-401K
-38.68%753K
-178.07%-1.76M
3,537.84%1.27M
-259.57%-667K
-25.26%3.86M
-14.66%1.23M
-24.72%2.25M
-Change in other current assets
85.89%-116K
93.21%-15K
11.89%-1.12M
37.70%-195K
110.42%119K
-732.31%-822K
-501.82%-221K
-223.98%-1.27M
-24.21%-313K
-715.71%-1.14M
-Change in other working capital
-34.64%-859K
-0.28%-713K
-203.78%-5.24M
-286.35%-1.92M
-1,777.14%-1.97M
-109.31%-638K
40.75%-711K
337.45%5.05M
59.48%-498K
86.66%-105K
Cash from discontinued investing activities
Operating cash flow
33.43%-10.02M
-6.66%-14.84M
-17.83%-50.58M
16.89%-9.9M
12.71%-11.71M
-147.88%-15.05M
-20.73%-13.91M
-152.84%-42.92M
-13.66%-11.91M
-129.14%-13.41M
Investing cash flow
Cash flow from continuing investing activities
-1,167.95%-190.89M
-1,201.33%-113.74M
-170.70%-41.19M
793.45%11.12M
-410.94%-61.45M
97.74%17.87M
-128.13%-8.74M
117.09%58.27M
-121.89%-1.6M
109.62%19.76M
Net PPE purchase and sale
83.62%-95K
30.88%-197K
71.30%-1.85M
74.95%-515K
81.35%-470K
35.41%-580K
70.65%-285K
-334.89%-6.45M
-75.28%-2.06M
-3,172.73%-2.52M
Net investment purchase and sale
-1,133.87%-190.79M
-1,242.86%-113.54M
-160.80%-39.34M
2,474.78%11.64M
-373.67%-60.98M
85.71%18.45M
-126.39%-8.46M
119.06%64.71M
-94.68%452K
110.85%22.28M
Cash from discontinued investing activities
Investing cash flow
-1,167.95%-190.89M
-1,201.33%-113.74M
-170.70%-41.19M
793.45%11.12M
-410.94%-61.45M
97.74%17.87M
-128.13%-8.74M
117.09%58.27M
-121.89%-1.6M
109.62%19.76M
Financing cash flow
Cash flow from continuing financing activities
423.67%2.77M
20,290.57%322.17M
11,809.60%59.55M
335.08%831K
56.61M
71.43%528K
157,900.00%1.58M
-99.87%500K
16.46%191K
0
Net common stock issuance
---455K
--320.51M
--56.53M
--0
--56.53M
--0
--0
--0
--0
----
Proceeds from stock option exercised by employees
509.85%3.22M
4.87%1.66M
503.60%3.02M
335.08%831K
--79K
71.43%528K
157,900.00%1.58M
-72.38%500K
16.46%191K
--0
Cash from discontinued financing activities
Financing cash flow
423.67%2.77M
20,290.57%322.17M
11,809.60%59.55M
335.08%831K
--56.61M
71.43%528K
157,900.00%1.58M
-99.87%500K
16.46%191K
--0
Net cash flow
Beginning cash position
585.31%213.62M
-61.68%20.02M
43.53%52.24M
-72.60%17.97M
-41.71%34.52M
-44.28%31.17M
43.53%52.24M
365.86%36.4M
66.46%65.57M
-76.47%59.22M
Current changes in cash
-6,018.19%-198.14M
1,018.79%193.6M
-303.36%-32.22M
115.41%2.05M
-360.69%-16.55M
2.26%3.35M
-207.80%-21.07M
-44.57%15.84M
-345.54%-13.33M
102.99%6.35M
End cash Position
-55.16%15.48M
585.31%213.62M
-61.68%20.02M
-61.68%20.02M
-72.60%17.97M
-41.71%34.52M
-44.28%31.17M
43.53%52.24M
43.53%52.24M
66.46%65.57M
Free cash flow
35.29%-10.12M
-5.90%-15.03M
-6.19%-52.43M
25.43%-10.42M
23.57%-12.18M
-124.27%-15.63M
-13.63%-14.2M
-167.46%-49.37M
-19.86%-13.97M
-168.66%-15.93M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 33.43%-10.02M-6.66%-14.84M-17.83%-50.58M16.89%-9.9M12.71%-11.71M-147.88%-15.05M-20.73%-13.91M-152.84%-42.92M-13.66%-11.91M-129.14%-13.41M
Net income from continuing operations 65.96%-5.96M15.46%-14.76M7.56%-58.29M26.81%-11.76M30.71%-11.57M-3.67%-17.51M-30.19%-17.46M-93.01%-63.06M-19.75%-16.07M-55.08%-16.7M
Depreciation and amortization 7.43%506K17.44%532K132.46%1.96M31.76%531K100.80%500K336.11%471K459.26%453K644.25%841K529.69%403K822.22%249K
Change In working capital -338.40%-7.35M-535.29%-4.45M-253.27%-6.55M-231.10%-1.1M-287.55%-3.08M-126.36%-1.68M67.09%-700K-51.64%4.28M5,673.33%836K-133.15%-795K
-Change in receivables -1,030.80%-6.98M30.80%-519K----------0--750K---750K------------
-Change in prepaid assets 21.30%-1.76M-171.01%-1.17M106.23%210K433.33%270K140.74%530K-281.43%-2.24M217.79%1.65M-86.65%-3.37M-400.00%-81K-2,925.58%-1.3M
-Change in payables and accrued expense 86.01%2.37M-204.20%-2.03M-110.38%-401K-38.68%753K-178.07%-1.76M3,537.84%1.27M-259.57%-667K-25.26%3.86M-14.66%1.23M-24.72%2.25M
-Change in other current assets 85.89%-116K93.21%-15K11.89%-1.12M37.70%-195K110.42%119K-732.31%-822K-501.82%-221K-223.98%-1.27M-24.21%-313K-715.71%-1.14M
-Change in other working capital -34.64%-859K-0.28%-713K-203.78%-5.24M-286.35%-1.92M-1,777.14%-1.97M-109.31%-638K40.75%-711K337.45%5.05M59.48%-498K86.66%-105K
Cash from discontinued investing activities
Operating cash flow 33.43%-10.02M-6.66%-14.84M-17.83%-50.58M16.89%-9.9M12.71%-11.71M-147.88%-15.05M-20.73%-13.91M-152.84%-42.92M-13.66%-11.91M-129.14%-13.41M
Investing cash flow
Cash flow from continuing investing activities -1,167.95%-190.89M-1,201.33%-113.74M-170.70%-41.19M793.45%11.12M-410.94%-61.45M97.74%17.87M-128.13%-8.74M117.09%58.27M-121.89%-1.6M109.62%19.76M
Net PPE purchase and sale 83.62%-95K30.88%-197K71.30%-1.85M74.95%-515K81.35%-470K35.41%-580K70.65%-285K-334.89%-6.45M-75.28%-2.06M-3,172.73%-2.52M
Net investment purchase and sale -1,133.87%-190.79M-1,242.86%-113.54M-160.80%-39.34M2,474.78%11.64M-373.67%-60.98M85.71%18.45M-126.39%-8.46M119.06%64.71M-94.68%452K110.85%22.28M
Cash from discontinued investing activities
Investing cash flow -1,167.95%-190.89M-1,201.33%-113.74M-170.70%-41.19M793.45%11.12M-410.94%-61.45M97.74%17.87M-128.13%-8.74M117.09%58.27M-121.89%-1.6M109.62%19.76M
Financing cash flow
Cash flow from continuing financing activities 423.67%2.77M20,290.57%322.17M11,809.60%59.55M335.08%831K56.61M71.43%528K157,900.00%1.58M-99.87%500K16.46%191K0
Net common stock issuance ---455K--320.51M--56.53M--0--56.53M--0--0--0--0----
Proceeds from stock option exercised by employees 509.85%3.22M4.87%1.66M503.60%3.02M335.08%831K--79K71.43%528K157,900.00%1.58M-72.38%500K16.46%191K--0
Cash from discontinued financing activities
Financing cash flow 423.67%2.77M20,290.57%322.17M11,809.60%59.55M335.08%831K--56.61M71.43%528K157,900.00%1.58M-99.87%500K16.46%191K--0
Net cash flow
Beginning cash position 585.31%213.62M-61.68%20.02M43.53%52.24M-72.60%17.97M-41.71%34.52M-44.28%31.17M43.53%52.24M365.86%36.4M66.46%65.57M-76.47%59.22M
Current changes in cash -6,018.19%-198.14M1,018.79%193.6M-303.36%-32.22M115.41%2.05M-360.69%-16.55M2.26%3.35M-207.80%-21.07M-44.57%15.84M-345.54%-13.33M102.99%6.35M
End cash Position -55.16%15.48M585.31%213.62M-61.68%20.02M-61.68%20.02M-72.60%17.97M-41.71%34.52M-44.28%31.17M43.53%52.24M43.53%52.24M66.46%65.57M
Free cash flow 35.29%-10.12M-5.90%-15.03M-6.19%-52.43M25.43%-10.42M23.57%-12.18M-124.27%-15.63M-13.63%-14.2M-167.46%-49.37M-19.86%-13.97M-168.66%-15.93M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion--------Unqualified Opinion----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data